Parnax Lab

Parnax Lab FCF per Share

The Free Cash Flow per Share of Parnax Lab (506128.BO) as of Nov 18, 2026 is 11.95 INR. In the previous year, Free Cash Flow per Share was -14.47 INR — a change of -182.58% (higher).

FCF per Share

11.95INR

YoY

-182.58%

Last updated:

Free Cash Flow per Share of Parnax Lab is 2025 11.95 INR. Free Cash Flow per Share of Parnax Lab was 2024 -14.47 INR. It decreases by -182.58% higher compared to the previous year.

The Parnax Lab FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
9.00 INR
Jan 1, 2019
-3.06 INR
Jan 1, 2020
-5.22 INR
Jan 1, 2021
-0.27 INR
Jan 1, 2022
-10.90 INR
Jan 1, 2023
8.70 INR
Jan 1, 2024
-14.47 INR
Jan 1, 2025
11.95 INR
The Parnax Lab FCF per Share history
YEARFCF per ShareYoY
11.95INR-182.58%
-14.47INR-266.31%
8.70INR-179.78%
-10.90INR+3,911.41%
-0.27INR-94.79%
-5.22INR+70.29%
-3.06INR-134.04%
9.00INR+982.94%
0.83INR-126.72%
-3.11INR-34.63%
-4.76INR-30.13%
-6.81INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Free Cash Flow per Share of Parnax Lab is 11.95 INR in 2025.

Free Cash Flow per Share of Parnax Lab changed from -14.47 INR to 11.95 INR, representing a -182.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Parnax Lab

All Key Metrics — Parnax Lab